Login E-loket

Baillet Latour Biomedical Award

This award aims to help young talented scientists to continue or consolidate their innovative and groundbreaking biomedical research project in Belgium.

Status

Budget call

In association with

Objective

On the initiative of the Baillet Latour Fund, the prestigious Baillet Latour Biomedical Award will be granted in 2027 to independent investigators in the early phase of their career to conduct basic, translational or clinical biomedical research in Belgium and to consolidate their independent research team and programme.

Features

  • Prize amounts to € 1,000,000 spread over 5 years;

  • Topic: Infection and Immunity;

  • The research project must be conducted in Belgium and involve fundamental, translational or clinical biomedical research;

  • Eligible expenses include personnel costs (excluding PI's salary), running costs, and equipment. Overhead costs are not eligible.

Profile and conditions

  • Applicants must hold a PhD degree awarded no more than 12 years prior to the deadline for applications i.e. 14 September 2014 (possibly extended in case of eligible career breaks, see regulations).

  • Applicants must be affiliated to a Belgian University, a Belgian University Hospital or an eligible Belgian Research Institute (see regulations).

  • Applicants must be affiliated to their institution until 30 June 2032.

Procedure

Applications must  be submitted by 14 September 2026 at the latest via the online application form.

Call schedule

  • Call deadline: 14 September 2026

  • First jury meeting: February 2027

  • Second jury meeting: March 2027

  • Award ceremony: April 2027

  • Start project: 1 July 2027

Regulations and downloads

More information, the regulations, application form and guide for applicants are available on https://www.blba.be/.

Fonds Baillet Latour

Since its establishment over 40 years ago, the Fund has rewarded and supported biomedical research. To this end, it has incepted several prestigious Prizes, among which the International Health Prize or the Clinical Prize which was later replaced by the Grant for Medical Research.

In order to amplify its impact in the biomedical field and to meet the actual challenges in R&D, the Fund has decided to redirect its support towards the development in Belgium of an ecosystem of high-level researchers to help accelerating the development of innovative research projects.

With the Baillet Latour Biomedical Award, the Baillet Latour Fund wishes to offer major support to basic, clinical or translational biomedical research in Belgium.

The Fund also wishes to strengthen the status and visibility of promising young researchers in Belgium and to support their development towards eminent independent research leaders in their field.

It additionally seeks to facilitate their grant applications to Belgian and European funding sources for their innovative research and intends to contribute to retaining promising new talents and to attract foreign ones.